RENAGADE

Welcome to the Brand page for “RENAGADE”, which is offered here for Renegade;design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; medical and scientific research in the field of cancer treatment and diagnosis; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines, rna and dna vaccines; research and development services in the field of antibodies; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the field of nucleic acids, rna and dna therapeutics for use in the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, muscular disorders, reproductive disorders, infectious diseases, blood disorders, sepsis, alopecia, and cognitive disorders; scientific research in the field of inhibitory nucleic acids, protein-encoding nucleic acids and polypeptide-encoding nucleic acids; pharmaceutical research and development; product research and development; scientific research and development; vaccine research and development in the field of rna and dna vaccines;.

Its status is currently believed to be active. Its class is unavailable. “RENAGADE” is believed to be currently owned by “Renagade Therapeutics LLC”.

Owner:
RENAGADE THERAPEUTICS LLC
Owner Details
Description:
RENEGADE;Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; medical and scientific research in the field of cancer treatment and diagnosis; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines, RNA and DNA vaccines; research and development services in the field of antibodies; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the field of nucleic acids, RNA and DNA therapeutics for use in the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, muscular disorders, reproductive disorders, infectious diseases, blood disorders, sepsis, alopecia, and cognitive disorders; scientific research in the field of inhibitory nucleic acids, protein-encoding nucleic acids and polypeptide-encoding nucleic acids; pharmaceutical research and development; product research and development; scientific research and development; vaccine research and development in the field of RNA and DNA vaccines;
Categories: RENEGADE